RMT Podcast #162 – Michael Jamieson, PhD

Regenerative Medicine Today welcomes Dr. Michael Jamieson. Dr. Jamieson is the Associate Director of the International Center for Regulatory Sciences, and an Assistant Professor Clinical Pharmacy, School of Pharmacy, University of Southern California. Dr. Jamieson discusses the relationship between industry and academic labs.

For more information about Dr. Jamieson, click here.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:

McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #160 – Rudy Mazzocchi

Regenerative Medicine Today welcomes Mr. Rudy Mazzocchi. Mr. Mazzocchi is the president and CEO of ELENZA, Inc. – a start-up that is developing the world’s first electronic “AutoFocal” Intraocular Lens. Mr. Mazzocchi discusses his entrepreneural methods at commercializing new technologies.

For more information about ELENZA, click here.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:

McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: , |

RMT Podcast #142 – Patrick Cantini

Regenerative Medicine Today welcomes back Mr. Patrick Cantini. Mr. Cantini is the Director of Strategic Scientific Collaborations for the McGowan Institute for Regenerative Medicine. Mr. Cantini discusses the opportunities available to corporate participants at the 2015 McGowan Institute Annual Retreat.

For more information about Mr. Cantini, click here.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:

McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #71 – Patrick Cantini

Regenerative Medicine Today welcomes Mr. Patrick Cantini.  Mr. Cantini is the Director of Scientific Collaborations at the McGowan Institute’s Center for Industry Relations.  Mr. Cantini discusses the importance and the process of establishing partnerships between the McGowan Institute and commercial enterprises and how this aids the transition from the laboratory studies to medical practice.

For more information about Mr. Cantini, please click here.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #58 – John Manzetti

Regenerative Medicine Today welcomes John Manzetti, President and Chief Executive Officer of the Pittsburgh Life Sciences Greenhouse (PLSG).  The PLSG is a public/private partnership for promoting the growth of the Western Pennsylvania region’s life sciences industries. The group invests in and supports regional life sciences companies in the areas of bioinformatics, bionanotechnology, diagnostics, medical devices, medical robotics, therapeutics and tools and services.

Mr. Manzetti overviews the programs of the PLSG and he also highlights the accomplishments and current initiatives of the PLSG.

For more information about the PLSG, please click here.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

By |Tags: |

RMT Podcast #54 – Thomas Tillet

Regenerative Medicine Today welcomes Thomas Tillett, who is the founding President and CEO of RheoGene. Under Mr. Tillett’s leadership, RheoGene established an innovative clinical development program with the RheoSwitch ™ Therapeutic System that has led to the first human clinical trial of a small molecule induced gene regulation system.

A Phase I clinical trial for melanoma was started in 2008. This represents a major advance for gene therapy therapeutics that offers the potential for significant improvements in safer and more controllable forms of gene therapy. RheoGene also received a $4.3 million grant from the Michael J. Fox Foundation to support the development of a novel therapeutic for Parkinson’s disease.

Mr. Tillett also led the successful merger of RheoGene Inc. with Intrexon Corporation at the beginning of 2007.

Host John Murphy.

For more information about the McGowan Institute for Regenerative Medicine, visit:
McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

RMT Podcast #22 – Doros Platika, MD

How do you turn a rust belt city into a world leader in biotechnology? Doros Platika, MD, has some ideas. Until December 1, 2006, Dr. Platika served as the president and chief executive officer of the Pittsburgh Life Sciences Greenhouse, a public/private partnership that invests in and supports the growth of life sciences companies in the Pittsburgh region with products in bioinformatics, bionanotechnology, diagnostics, medical devices, medical robotics, therapeutics, and related tools and services. In this podcast, you’ll hear Dr. Platika review the accomplishments of the Pittsburgh Life Sciences Greenhouse, and he’ll talk about his new job: helping to get funding to study the world’s oldest people.

Dr. Platika is the chairman of the Supercentenarian Research Foundation, a new organization designed to raise funding for studies of supercentenarians, or people who have lived more than 110 years. Dr. Platika wants to know: Why have the very aged survived as long as they have? Are they less susceptible to the common diseases that slow down the rest of us? Ultimately, Dr. Platika hopes the foundation will contribute to the discovery of products that help people fight degenerative and other conditions associated with aging and maintain their mobility and quality of life.

Hosts Leah Kauffman and John Murphy. Interview by Leah Kauffman.

For more information about the McGowan Institute for Regenerative Medicine, visit:

McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook
McGowan Institute on Twitter

RMT Podcast #14 – Dr. Malla Padidam and David Smith, JD

In podcast #14 we’ll meet two more researchers who visited Pittsburgh for the 2006 Regenerate World Congress.

Dr. Malla Padidam of the biotech company RheoGene (now merged with Intrexon Corporation) describes their gene switch, a molecule that can turn a gene on or off at a particular time to precisely guide the growth of transplanted tissues or cells. Another RheoGene product uses engineered enzymes that recognize certain sequences of DNA, so that when a scientist introduces a new gene it inserts into just one location. This is an improvement over current genetic engineering technology that can’t control where in a chromosome a gene inserts itself, possibly hindering whether or not it functions.

David S. Smith of the Pittsburgh office of Pepper Hamilton LLP is a corporate lawyer who helps scientists transform their work from laboratory investigations into clinical products. Mr. Smith focuses on intellectual property transactions, regulatory issues, and licensing. His corporate practice is concentrated in the organization, financing and growth of life sciences companies, and he is an authority on the legal issues surrounding the use of human biological materials. Mr. Smith also is the co-founder and co-chair of the ETG Executive Forum, an annual workshop on the commercialization of engineered tissue products and regenerative therapies, and he co-authors a column on FDA regulatory initiatives that appears monthly in Genetic Engineering News.

Hosts Leah Kauffman and John Murphy. Interview by Leah Kauffman.

For more information about the McGowan Institute for Regenerative Medicine, visit:

McGowan Institute Research Site
McGowan Institute Patient Site
McGowan Institute on Facebook

Load More Posts